Project Grant HT94252410083
Award Date
1/15/24
Completion Date
1/14/26
Dollars Obligated
$317K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Austin, TX 78712, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
This $363,160 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) is funding bioresorbable heart valve research at the University of Texas Southwestern Medical Center in Dallas, TX. The grant supports advanced biomedical investigations focused on developing innovative therapeutic approaches for cardiovascular diseases, with a specific emphasis on novel heart valve technologies. The 2-year project aims to explore...
The University of Cincinnati received a $243,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Characterization of Novel Perivascular Lesions Caused by Specific Deletion of TSC2 in Hematopoietic Cells." The award period is from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program supports biomedical research aimed at improving the...
The Department of the Army Medical Command awarded a $993,366 Project Grant to Augusta University Research Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to modulate hemostasis and metabolic homeostasis in order to treat hemorrhagic shock. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development program seeks to improve military and...
This $2,399,474.00 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will support the University of Texas Medical Branch at Galveston (UTMB) in conducting research on "Wound Stabilization to Prevent Combat Infections." The award, which runs from September 1, 2024 through August 31, 2028, will enable UTMB to develop innovative medical solutions for addressing infectious disease challenges...
The federal Project Grant award of $422,299.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on February 1, 2025, supports research by Texas A&M University System Health Science Center (TAMU HSC) to study inhibiting renal lymphatic expansion to mitigate nephrotic syndrome. The research aims to develop innovative medical solutions addressing complex healthcare challenges relevant to military...
This $2.29 million Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research into the "Regulation of ALK1 Signaling in the Endothelium" from September 1, 2021 through August 31, 2025. The University of Pittsburgh will conduct the research as the primary awardee. A $200,000 subaward to the University of Massachusetts Medical School will support related research activities. Through this funding, the...
The University of Texas Health Science Center of San Antonio was awarded a $620,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from May 2022 through April 2026 to target the lysosomal acid lipase A enzyme to induce cellular stress in ovarian cancer. As part of the Military Medical Research and Development program's goals to transform military and public...
This $249,986 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) supports research at the University of Texas Southwestern Medical Center to understand the genetic determinants of multiple sclerosis (MS) progression using longitudinal cohorts. The research aims to transform healthcare for military service members and the general public by developing innovative approaches to disease...
The University of Arizona was awarded a $2,611,139 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to support research on Novel Therapeutics for Pulmonary Hypertension. The four-year award beginning May 1, 2022 will fund the development of new drug therapies to treat pulmonary hypertension, a condition affecting blood pressure in the lungs that can impact military service members. As part of the work,...